Putnam Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-667,400
Closed -$3.54M 1325
2016
Q3
$3.54M Sell
667,400
-8,302
-1% -$44.1K 0.01% 680
2016
Q2
$4.47M Hold
675,702
0.01% 664
2016
Q1
$3.16M Buy
675,702
+2,539
+0.4% +$11.9K 0.01% 815
2015
Q4
$3.4M Hold
673,163
0.01% 809
2015
Q3
$2.37M Buy
673,163
+351,857
+110% +$1.24M 0.01% 943
2015
Q2
$3.21M Buy
321,306
+166,946
+108% +$1.67M 0.01% 896
2015
Q1
$1.97M Buy
+154,360
New +$1.97M ﹤0.01% 1059